首页> 外国专利> METHOD FOR QUALITATIVE ASSESSMENT OF ADAPTABILITY TO REMOVABLE PALATAL DENTURES BY ORAL FLUID BIOMARKERS OF PATIENTS SUFFERING DENTOFACIAL NEW GROWTHS

METHOD FOR QUALITATIVE ASSESSMENT OF ADAPTABILITY TO REMOVABLE PALATAL DENTURES BY ORAL FLUID BIOMARKERS OF PATIENTS SUFFERING DENTOFACIAL NEW GROWTHS

机译:口腔颌面新增长患者口腔流体生物标记物对可去除的义齿适应性的定性评估方法

摘要

FIELD: medicine.SUBSTANCE: enzyme immunoassay is conducted to determine a quantitative level of patient's oral fluid biomarkers prior to or at least 30 minutes after meals. The biomarker is matrix metalloproteinase (MMP 8) or matrix metalloproteinase (MMP 9). For a clinical reference group, MMP 8 is taken at 21.65-41.85 ng/ml; if the level is 171.25-524.7 ng/ml, a low adaptability is diagnosed, whereas the value of 58.7-162.7 ng/ml shows a complete functional adaptation of the patient suffering dentofacial new growths to removable palatal dentures. For a clinical reference group, MMP 9 is taken at 134.9-207.7 ng/ml; if the level is 526.5-919.1 ng/ml, a low adaptability is diagnosed, whereas the value of 236.8-492.3 ng/ml shows a complete functional adaptation of the patient suffering dentofacial new growths to removable palatal dentures.EFFECT: invention enables providing more accurate instant diagnosis for the adaptability to removable palatal dentures in the patients suffering dentofacial new growth on the day of visiting a doctor.3 cl, 6 ex
机译:领域:医学。研究对象:就餐前或饭后至少30分钟进行酶免疫测定以确定患者口腔液生物标志物的定量水平。生物标志物是基质金属蛋白酶(MMP 8)或基质金属蛋白酶(MMP 9)。对于临床参考组,MMP 8的摄入量为21.65-41.85 ng / ml;如果该水平为171.25-524.7 ng / ml,则诊断为适应性低,而58.7-162.7 ng / ml的值则表明具有牙面新生长的患者完全可适应adaptation义齿。对于临床参考组,MMP 9的摄入量为134.9-207.7 ng / ml;如果该水平为526.5-919.1 ng / ml,则诊断为适应性低,而236.8-492.3 ng / ml的值则表明患有牙面新生长的患者完全可适应pa义齿的功能适应性。在就诊当日出现牙面新生长的患者中,对可移动式pa假牙的适应性进行准确的即时诊断。3cl,6 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号